FineHeart breaks new ground with successful removal of the ICOMS FLOWMAKER® in a 90-day in-vivo trial


Towards a new standard for device indication:
Implantation for temporary or permanent use

This operation to remove a cardiac assistance device with a beating heart is a world first. This achievement, allows for the use of the ICOMS FLOWMAKER® either as temporary or permanent treatment depending on the severity of the pathology, paves the way for the First implantation in Human.


“ICOMS continues to show promise as an easily implantable device with the potential for lowering the complications experienced with current generation LVADs

The technology’s unique ability to support the natural heart function addresses a significant unmet clinical need and could improve the quality of life for hundreds of thousands of patients suffering from severe heart failure

WELCOME TO FINEHEART


A Healthier Life With Every Beat

FineHeart is creating the ICOMS:

a game changing therapy
for long term circulatory assistance
addressed to severe heart failure patients.

BIOVISION 25

BIG BOOSTER 2016

AGBM MEDICAL TECHNOLOGY INNOVATION

TECH TOUR HELSINKI 2017

EY ENTREPRENEUR OF THE YEAR

EUROPEAN VENTURE CONTEST 2017

LATEST NEWS